(+)-N-3-Benzylnirvanol
SIGMA/B8686 - ≥98% (HPLC), powder
Synonym: (5S)
CAS Number: 790676-40-3
Empirical Formula (Hill Notation): C18H18N2O2
Molecular Weight: 294.35
MDL Number: MFCD09840024
Linear Formula: C18H18N2O2
Product Type: Chemical
| assay | ≥98% (HPLC) |
| form | powder |
| InChI | 1S/C18H18N2O2/c1-2-18(15- |
| InChI key | ZMZDHUHMXXALFX-SFHVURJKSA |
| Quality Level | 100 ![]() |
| SMILES string | CC[C@]1(NC(=O)N(Cc2ccccc2 |
| solubility | DMSO: >20 mg/mL |
| H2O: insoluble | |
| storage temp. | 2-8°C |
| Application: | (+)-N-3-Benzylnirvanol may be used as a cytochrome P450 2C19 (CYP2C19) inhibitor in a comparison study to treat cocktail and individual substrates for the screening for potent cytochrome P450 (CYP) inhibition. It may also be used in comparative studies to investigate its potential as CYP and non-CYP selective inhibitors of CYP2C19 in suspended human hepatocytes. |
| Biochem/physiol Actions: | (+)-N-3-Benzyl-nirvanol is a potent selective CYP2C19 inhibitor. |
| Biochem/physiol Actions: | (+)-N-3-Benzyl-nirvanol is a potent selective CYP2C19 inhibitor. CYP2C19 has a high frequency of drug resistance; highly polymorphic. |
| Biochem/physiol Actions: | (+)-N-3-Benzylnirvanol serves as an inhibitor of cytochrome P450 2B6 (CYP2B6). |
| Packaging: | 5, 10 mg in glass bottle |
| Symbol | ![]() GHS07,GHS09 |
| Signal word | Warning |
| Hazard statements | H302 - H319 - H400 |
| Precautionary statements | P264 - P270 - P273 - P280 - P301 + P312 - P305 + P351 + P338 |
| Hazard Codes | Xn,N |
| Risk Statements | 22-36-50 |
| Safety Statements | 26-61 |
| RIDADR | UN 3077 9 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12161501 |



